retatrutide how often to take VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Dosing Guide: 2mg–12mg Protocol

Appetite suppression is well-established at this stage, and meaningful weight loss is typically underway

A 2025 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders found that tirzepatide (the active ingredient in Mounjaro and Zepbound) reduced hsCRP by approximately 33% and IL-6 by approximately 18% compared to placebo across patients with and without diabetes. A growing body of research suggests this effect occurs through direct action on the NF-B pathway, a master switch of inflammation

View Weight Loss Treatment Sources

Regular monitoring of hormonal health is vital for identifying any imbalances early on